The Food Safety and Standards Authority of India (FSSAI) has sent notices to several brands for using unverified claims like 'fresh', 'vegan', and '100% organic'. This regulatory action aims to stop deceptive marketing and protect consumer interests across the food sector.
The Food Safety and Standards Authority of India (FSSAI) has initiated a strict enforcement drive against food companies making unsubstantiated claims on their product packaging. The regulator has issued formal notices to multiple brands, flagging labels that it considers misleading or deceptive to the average consumer.
Among the brands receiving notices is Heritage Fresh for its 'Fresh Paneer' labeling, which the regulator has questioned. Similarly, La Casa has been scrutinized for its hazelnut chocolate spread, specifically regarding labels claiming the product is 'vegan', '100% organic', and 'all natural'. The FSSAI has also targeted Cipzer Nutraceuticals over its juice capsules, which were marketed with claims of being 'FSSAI approved' and derived from 'organic vegetables'.
Regulatory Focus on Product Definitions
This move is part of a larger ongoing campaign to standardize product information. In earlier actions, the FSSAI raised concerns regarding the marketing of energy drinks. Brands such as Hell Energy Drink, Adrenaline Rush, Red Bull, and Sting were flagged for using the term 'energy drink' on their products. The regulator clarified that the current Food Safety and Standards Regulations do not define a specific standard for the category of 'energy drinks', creating potential confusion for buyers about exactly what they are consuming.
Impact on Food Industry Claims
The regulator has emphasized that companies are not allowed to make therapeutic or functional health claims—such as promises that a product can boost energy or improve focus—unless these claims are specifically backed by scientific evidence and permitted under the Food Safety and Standards Act, 2006. For investors and stakeholders in the food and beverage industry, this indicates a period of heightened compliance risk. Companies that rely heavily on health-focused marketing or premium labels to justify pricing may face increased costs if they are forced to modify their packaging or reformulate products to meet strict regulatory definitions.
The key monitorable for the industry moving forward will be how companies adjust their labeling strategies in response to these notices. Investors should track whether such regulatory interventions lead to increased legal and compliance expenses, or if they result in mandatory product recalls or packaging changes that could impact the brand equity and profit margins of the affected companies.